ArhGAP9, a novel MAP kinase docking protein, inhibits Erk and p38 activation through WW domain binding

We have identified human ArhGAP9 as a novel MAP kinase docking protein that interacts with Erk2 and p38α through complementarily charged residues in the WW domain of ArhGAP9 and the CD domains of Erk2 and p38α. This interaction sequesters the MAP kinases in their inactive states through displacement...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Ang, Boon K, Lim, Chun Y, Koh, Sharon S, Sivakumar, Neelamegam, Taib, Shahrizan, Lim, Kim B, Ahmed, Sohail, Rajagopal, Guna, Ong, Siew H
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2007
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC1805438/
https://ncbi.nlm.nih.gov/pubmed/17284314
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1750-2187-2-1
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak